COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 230: Articles 2291-2300  | Next

Characteristics of JN.1-derived SARS-CoV-2 subvariants SLip, FLiRT, and KP.2 in neutralization escape, infectivity and membrane fusion
Li, P., Faraone, J. N., Hsu, C. C., Chamblee, M., Zheng, Y.-M., Carlin, C., Bednash, J. S., Horowitz, J. C., Mallampalli, R. K., Saif, L. J., Oltz, E. M., Jones, D., Li, J., Gumina, R. J., Xu, K., Liu, S.-L.
10.1101/2024.05.20.595020 — Posted: 2024-05-21
Plasmacytoid dendritic cells are dispensable or detrimental in murine systemic or respiratory viral infections
Ngo, C., Rahmani, K., Valente, M., Collinet, N., Bessou, G., Fabregue, M., Sharkaoui, S., Mazzoli, S., Pierini-Malosse, C., Sansoni, A., Fiore, F., Laprie, C., GAYA, M., Gregoire, C., Broggi, A., Milpied, P., Escaliere, B., Phong, T., Fallet, M., Chasson, L., Tran, H., Le Bert, M., Malissen, B., ZARUBICA, A., DALOD, M., Tomasello, E.
10.1101/2024.05.20.594961 — Posted: 2024-05-21
Impact of COVID-19 pandemic on rates of congenital heart disease procedures among children: Prospective cohort analyses of 26,270 procedures in 17,860 children using CVD-COVID-UK consortium record linkage data.
Karthikeyan Suseeladevi, A., Denholm, R., Babu-Narayan, S., Sinha, S., Stoica, S., Dong, T., Angelini, G., Sudlow, C., Walker, V., Brown, K., Caputo, M., Lawlor, D. A., CVD-COVD-UK/COVID-IMPACT Consortum
10.1101/2024.05.20.24307597 — Posted: 2024-05-20
COVID-19 transmission dynamics in South Korea prior to vaccine distribution
Suh, J., Galanti, M., Yamana, T. K., Perini, M., Kaondera-Shava, R. F., Shaman, J.
10.1101/2024.05.17.24307538 — Posted: 2024-05-20
A Comparison of CXR-CAD Software to Radiologists in Identifying COVID-19 in Individuals Evaluated for Sars CoV 2 Infection in Malawi and Zambia
Linsen, S., Kamoun, A., Gunda, A., Mwenifumbo, T., Chavula, C., Nchimunya, L., Tsai, Y., Mulenga, N., Kadewele, G., Nahache, E., Sunkutu, V., Shawa, J., Kadam, R., Arentz, M.
10.1101/2024.05.19.24307603 — Posted: 2024-05-20
OpenSAFELY: Effectiveness of COVID-19 vaccination in children and adolescents.
Andrews, C. D., Parker, E. P. K., Horne, E., Walker, V., Palmer, T., Schaffer, A. L., Green, A. C., Curtis, H. J., Walker, A. J., Bridges, L., Wood, C., Speed, V., Bates, C., Cockburn, J., Parry, J., Mehrkar, A., MacKenna, B., Bacon, S. C., Goldacre, B., Hernan, M. A., Sterne, J. A., The OpenSAFELY Collaborative, , Hulme, W. J.
10.1101/2024.05.20.24306810 — Posted: 2024-05-20
SARS-CoV-2 transmission dynamics in Mozambique and Zimbabwe during the First Three Years of the Pandemic
Kaondera-Shava, R. F., Galanti, M., Perini, M., Suh, J., Farley, S. M., Chicumbe, S., Jani, I., Cassy, A., Macicame, I., Manafe, N., El-Sadr, W., Shaman, J.
10.1101/2024.05.20.24307570 — Posted: 2024-05-20
SARS-CoV-2 variants from long-term, persistently infected immunocompromised patients have altered syncytia formation, temperature-dependent replication, and serum neutralizing antibody escape
Wouters, C., Sachithanandham, J., Akin, E., Pieterse, L., Fall, A., Truong, T. T., Bard, J. D., Yee, R., Sullivan, D. J., Mostafa, H. H., Pekosz, A.
10.1101/2024.05.18.594818 — Posted: 2024-05-20
ISGylation of the SARS-CoV-2 N protein by HERC5 impedes N oligomerization and thereby viral RNA synthesis
Zhu, J., Liu, G., Goins, C. M., Stauffer, S. R., Gack, M. U.
10.1101/2024.05.15.594393 — Posted: 2024-05-20
Proteogenomic analyses identify coagulation factor XI as a thromboinflammatory mediator of long COVID
Schuermans, A., Verstraete, A., Lammi, V., Nakanishi, T., Ardissino, M., Van den Eynde, J., Sun, B., Georgakis, M. K., Van Weyenbergh, J., Lewandowski, A. J., Raman, B., Ollila, H. M., Burgess, S., Natarajan, P., Honigberg, M. C., Freson, K., Vanassche, T., Verhamme, P.
10.1101/2024.05.17.24307553 — Posted: 2024-05-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).